Aarti Pharmalabs Limited (APL) is a manufacturer of APIs, intermediates, new chemical entities (NCEs), and xanthine derivatives. Based in India, APL provides both R&D and manufacturing services to generics and innovator clients internationally. The company specializes in generic APIs, generic intermediates, and xanthine products. Their end-to-end CDMO services include a focus on phase I, II, and III trials, as well as commercialization. APL's flagship proprietary caffeine product makes it a preferred partner of the beverages, nutraceuticals, and pharmaceutical industries.